Galectin Therapeutics Inc... (GALT)
NASDAQ: GALT
· Real-Time Price · USD
4.46
0.13 (3.00%)
At close: Oct 06, 2025, 3:14 PM
13F Institute Ownership
Total Institutes of 90 in Galectin Therapeutics reduced their positions with a decrease of 5 investors compared to the previous quarter. An additional 556.05K shares, as total invested capital grew by $10.49M with ownership percentage increasing from 15.67% to 16.55%.
Options Activity
Institutions are holding more Puts Contracts as Calls Contracts, indicating a bearish sentiment.
Put/Call 2.646
2.65
Call Flow 133,500
27%
Put Flow 353,300
73%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Vanguard Group Inc | 3.46% | 2.18M | -0.36% | 4.61M | < 0.01% | Aug 11, 2025 |
| Advisor Group Holdings, Inc. | 2.00% | 1.27M | +3.43% | 2.67M | < 0.01% | Sep 04, 2025 |
| Blackrock, Inc. | 1.41% | 891.88K | -36.97% | 1.88M | < 0.01% | Aug 12, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.